FDA Drug Application (202813) for QNASL by TEVA BRANDED PHARM

Back to FDA Applications sponsored by TEVA BRANDED PHARM

Application Number202813
Product Number001
FormAEROSOL, METERED;NASAL
Dosage0.08MG/ACTUATION
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameQNASL
Active IngredientBECLOMETHASONE DIPROPIONATE



Back to FDA Applications sponsored by TEVA BRANDED PHARM

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.